Principles of Biochemistry 6 |Blood Coagulation| Class Notes |HarvardX

Blood Clot

digraph F { rankdir = "LR"

subgraph cluster_0{
label = “Human Blood Clot”
Platelets
Fibrin
Platelets -> Platelets_E
Fibrin -> Fibrin_E
subgraph A {
rank = 1
Fibrin
Fibrin_E
}
subgraph B {
rank = 2
Platelets
Platelets_E
}
Platelets_E [shape = box, label= “form a soft plug”]
Fibrin_E [shape = box, label = “fibrous protein forms a mesh”]
}
}

digraph F { rankdir = "LR" subgraph cluster_1{ node [shape= none] label ="Three Phases of Blood Coagulation" Initiation [label = "1. Initiation"] Extension [label = "2. Extension"] Stabilization [label = "3. Stabilization"] Cascade [label = "Coagulation Cascade", fontcolor = "red"] }

subgraph cluster_2 {
node [shape = box]
In_1 [label = “Von Willebrand factor (vWF) attaches to the collagen fibers.”]
In_2 [label = “unfolding of the fiber and expose the bind sites of the vWF”]
In_3 [label = “attach the surface of the platelets”]
In_4 [label = “platelets started to attach the lesion site”]
label = “Initiation”
In_1 -> In_2 -> In_3 -> In_4
subgraph A {
rank = same
In_4
In_3
In_2
In_1
}
}
Initiation -> In_1

subgraph cluster_3 {
label = “Extension”
Extension_1 [shape = none,
label = “Consistant the recruitment of addition platelets.
It was contributed by the fibrinogen,
which has two binding sites for intergins.
The release of ADP and thromboxane
A2 by activate platelets attached.
to form a soft plug”]
}
Extension -> Extension_1

subgraph cluster_4 {
label = “Stabilization”
Stabilization_Ex [shape = none,
label = “Conversion of fibrinogen into fibrin
and the polymerization of the fibrin
into a network of fibers”]
subgraph cluster_4_1{
node [shape =underline]
ssub1 [label = “1. collagen”]
ssub2 [label = “2. Thrombin: initiate”]
ssub3 [label = “3. ADP/TxA: \n initiate pyhsical respons”]
ssub4 [laebl = “5. Platelets Shell”]
label = “Four molecules”
fontcolor = “blue”
}
}
Stabilization -> ssub1
}

Initiation

  • Von Willebrand factor attaches to the collagen fibers.
  • unfolding of the fiber and expose the bind sites of the vWWF
  • attach the surface of the platelets
  • platelets started to attach the lesion site.

Extension

consistant the recruitment of addition platelets.
It was contributed by the fibrinogen, which has two binding sites for intergins.

The release of ADP and thromboxane A2 by activate platelets attached.
-> soft plug

Stabilization

Conversion of fibrinogen into fibrin and the polymerization of the fibrin into a network of fibers.
Stabilize anchored by thrombin.

Four molecules:

  • collagen
  • Thrombin: initiate
  • ADP/TxA: initiate pyhsical respons
  • platelets shell

Fibrinogen

The third most abundant protein in blood plasma, consisting of two C-terminal domains.

From fibrinogen to fibrin:

  • controlled by the activation of the thrombin.
  • cleave a small portion (18~20) to release 2 binding sites.
  • binding sites could react with other fibrin’s C-terminal
  • turned into a meshwork of fibers.
  • meshwork extended from the base of the platelet plug into the lesion
  • which tenses the platelet plug

A positive feedback process

Blood Vessel Layers
© Wayne W. LaMorte; 2016

As shown above, the blood vessel has a few layers. Surrounding the endothelium, cells in the second layer of the vessel are characterized by expression tissue factors that could trigger blood coagulation.

The lesion would expose the second layer and release the tissue factors.

Two pathway of the coagulation cascade

  • Extrinsic (first)
  • Intrinsic: activated plates.
Two pathway of the coagulation cascade

Extrinsic

VII: coagulation factor VII
VIIa: activated coagulation factor VII
TF + VII -> TF - VIIa (composite)
VIIa: IX -> IXa
IXa: X -> Xa
Xa + Va + TF
Xa + Va + TF: pro-thrombin -> thrombin
thrombin: fibrinogen -> fibrin

thrombin: Va
trhombin -> VIIIa
VIIIa: X -> Xa
thrombin: XIIIa
XIIIa: polymerization

Intrinsic path

Initiated when some hazer or foreign be recognized.

XII -> XIIa
XIIa: XI -> XIa
like above.

Misbehavior of the Intrinsic pathway could cause blood clots to cause disease.

digraph F { "marr0001" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0002" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0003" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0004" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0005" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0006" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0007" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0008" [shape=diamond,style=filled,label="",height=.1,width=.1] ; "marr0009" [shape=diamond,style=filled,label="",height=.1,width=.1] ;

TF [label =“tissue factor”]
TF_VII [label = “{Xa|Va}|{TF|VII}”
shape = record]
Pthrombin [label = “Pro-thrombin”]
Polymerization [shape = box]

TF -> “marr0001”
VII-> “marr0001” -> TF_VII

TF_VII:f0 -> marr0002 [style = dotted]
IX -> marr0002 [dir = none]
marr0002 -> IXa
IXa -> marr0003 [style = dotted]
marr0003 -> Xa
X -> marr0003 [dir = none]
Xa -> marr0004 -> TF_VII:f2
Va -> marr0004 -> TF_VII:f3

TF_VII:f3 -> marr0005 [style = dotted]
Pthrombin -> marr0005 [dir = none]
marr0005 -> thrombin
thrombin -> marr0006 [style = dotted]
marr0006 -> fibrin
fibrinogen -> marr0006 [dir = none]

thrombin -> XIIIa [style = dotted]
XIIIa -> marr0007 [style = dotted]
marr0007 -> Polymerization
fibrin -> marr0007 [dir =none]
subgraph cluster_0 {
label = “Extrinsic Pathway”
TF
VII
TF_VII
IXa
IX
X
Xa
Va
Pthrombin
thrombin
marr0001
marr0002
marr0003
marr0004
marr0005
marr0006
marr0007
fibrin
fibrinogen
XIIIa
Polymerization
fibrin
}

subgraph cluster_i {
label = “Intrinsic Pathway”
XII -> marr0008 -> XIIa
XIIa -> marr0009 [style= dotted]
XI -> marr0009 [dir = none]
marr0009 -> XIa
}
XIa -> marr0002 [style = dotted]
}

The stop of the coagulation

Thrombin: control the size of the blood clot.

Thrombin + Protein S complexes -> bind to thrombomodulin: form a ternary complex

ternary complex -> Protein C
Protein C: Inactivation of IX and X to stop the clot.

Two additional levels of inhibition:

  1. TFPIa binds and inactivates the ternary complexes (TF, VIIa, and Xa)
  2. Antithrombin 3 binds irreversibly to thrombin. It also responds to the inactivation of the IX, X, XI, and XII.

Thrombus Detection

Thrombus

blood clots
© Peter Caravan, Ph.D.
  • Blood clot that forms in the arteries or veins of the body
  • Can cause stroke, coronary artery disease, pulmonary embolism, deep vein thrombosis
  • Affects millions of people and costs billions of dollars worldwide.
  • Developing new imaging tools is essential for diagnosis and monitoring disease progression

Fibrin imaging

  • Fibrin is an attractive target for thrombus image
    • only present in blood clots and wound hearling
    • not found in circulating blood
  • High density for disease, no background.

Phage Display

  1. Phage library filter:
    • incubate the phage with fibrin and collect the phage which bind with it.
  2. Phage proliferation:
    • Incubate the phage with E. coli to proliferate them.
  3. Improve the affinity:
    • Repeat the phase 1 and 2 over and over again.
  4. Characterize those phage
  5. Magnetic Resonance Imaging (MRI)
    • Need large magnetic field and radiofrequency energy for detection

Magnetic Resonance Imaging (MRI)

  1. It is able to detect the Hydrogen molecules and mobile molecules, which are mainly water and fats.
  2. Metal is another important resource, Gadolinium ion, especially.
Gd DTPA-BMA Thrombus Detection
© pubchem:24847884 © Penka A Atanassova
  • Label with radioactive isotope
    • Positron Emission Tomography
  • Label with fluorescent dye
    • Fluorescent microscopy
  • Label with EP-2014R:
    • Fibrin-binding peptide coupled to 4 Gadolinium chelates.
    • Binds reversibly and specifically to fibrin
    • Low affinity for fibrinogen, albumin and other components of plasma
    • High relaxivity: makes clots bright.

Principles of Biochemistry 6 |Blood Coagulation| Class Notes |HarvardX

https://karobben.github.io/2021/03/31/LearnNotes/edx-biochm-6/

Author

Karobben

Posted on

2021-03-31

Updated on

2024-01-11

Licensed under

Comments